Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion description "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion evidence source_evidence_literature NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion SIO_000772 18759551 NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion wasDerivedFrom befree-20140225 NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion wasGeneratedBy ECO_0000203 NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- befree-20140225 importedOn "2014-02-25" NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.